Qnovia
PrivateLast Round
Series B
Dec 10, 2024
Est. Valuation
$300M
Total Funding Raised
$35.25M
Company Overview
Qnovia is a pharmaceutical and medtech company that develops proprietary inhalation device technologies and drug delivery platforms to improve patient outcomes, with an initial focus on smoking cessation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Patient Engagement, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qnovia Comparables
Compare Qnovia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pneuma Respiratory | 82% | |
| Miist Therapeutics | 77% | |
| Philip Morris International | 71% | |
Qnovia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 10, 2024 | ||||
| Series A | Sep 28, 2022 | ||||
| Seed | Jan 13, 2020 |
Key People
Founding team and executive leadership
Qnovia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vice Ventures | Series A, Series B |
| Poseidon Asset Management | Seed |
| Compass Rose Asset Management | Series B |
| Gaingels | Series A, Series B |
| Blue Ledge Capital | Series A, Series B |
| DG Ventures | Series A, Seed |
| Third Lake Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 164% MoM.
- Dec 10, 2024
$16M round led by Gaingels, Blue Ledge Capital, Evolution VC, and Vice Ventures.
Qnovia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qnovia's valuation, stock price, and market status.